Basaran, O. Et Al. 2017. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.43, no.2 , 157-165.

Basaran, O., Dogan, V., Beton, O., Tekinalp, M., Aykan, A. C., Kalaycioglu, E., ... Bolat, I.(2017). Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.43, no.2, 157-165.

Basaran, Ozcan Et Al. "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study," JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.43, no.2, 157-165, 2017

Basaran, Ozcan Et Al. "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.43, no.2, pp.157-165, 2017

Basaran, O. Et Al. (2017) . "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.43, no.2, pp.157-165.

@article{article, author={Ozcan Basaran Et Al. }, title={Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study}, journal={JOURNAL OF THROMBOSIS AND THROMBOLYSIS}, year=2017, pages={157-165} }